BRAF and melanoma: We observed that DETS is effectively down-regulating the expression of oncogenic BRAF which is shown to be mutated and activated in A375 cells (Figure 7A) and Brn-2, a molecule highly over-expressed in BRAF mutant melanoma cells and (Figure 7A).